Ligand validation:3VGW

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3VGW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VGW_NAG_B_1125	51%	5%	0.146	0.899	1.64	3.76	1	8	0	0	100%	0.9333
3VGW_NAG_D_1125	44%	3%	0.141	0.866	2.15	3.76	2	6	3	0	100%	0.9333
3VGW_NAG_F_1125	42%	2%	0.152	0.871	2.21	4.17	3	6	0	0	100%	0.9333
3VGW_NAG_A_1125	39%	7%	0.168	0.875	2.31	2.62	4	3	0	0	100%	0.9333
3VGW_NAG_H_1125	39%	4%	0.164	0.869	2.26	3.23	4	9	4	0	100%	0.9333
3VGW_NAG_E_1125	37%	15%	0.178	0.874	1.32	2.39	1	6	6	0	100%	0.9333
3VGW_NAG_G_1125	36%	3%	0.173	0.865	2.8	3.14	6	5	3	0	100%	0.9333
3VGW_NAG_C_1125	28%	7%	0.203	0.853	1.9	2.99	3	5	0	0	100%	0.9333
5IRW_NAG_A_201	72%	56%	0.116	0.94	0.8	0.91	-	-	1	0	100%	0.9333
5IRU_NAG_A_201	71%	64%	0.115	0.934	0.71	0.68	-	-	0	0	100%	0.9333
5MYQ_NAG_A_302	65%	28%	0.111	0.913	0.82	2.05	-	1	0	0	100%	0.9333
3VHM_NAG_D_1125	53%	14%	0.109	0.868	1.38	2.42	2	3	5	0	100%	0.9333
3VHH_NAG_D_1125	53%	19%	0.142	0.901	1.33	2.11	3	4	3	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.